Hyperoxaluria: Clinical Trials

1 trial for Hyperoxaluria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Hyperoxaluria: new trials by email Literature Review of Hyperoxaluria trials Research Report on Hyperoxaluria

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria
BMN 255, Placebo - Hyperoxaluria, Nonalcoholic Fatty Liver Disease
Phase 1WithdrawnBioMarin Pharmaceutical2023-09-262024-06-11

Narrower conditions

Kidney Calculi (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Calculi (1)  ·  Digestive System Diseases (1)  ·  Fatty Liver (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Liver Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephrolithiasis (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urinary Calculi (1)  ·  Urogenital Diseases (1)  ·  Urolithiasis (1)  ·  Urologic Diseases (1)

Sponsors

BioMarin Pharmaceutical (1)

Countries

United States (1)